Dr. Holger G. Adelmann, MD PhD, serves as the Senior Vice President/Managing Director for DIA EMEA. He holds a board certification in Clinical Pharmacology from the North Rhine medical council, Germany. After clinical training in internal medicine, he joined the pharmaceutical industry in 1989 where he worked in various leading positions with Bayer, Tropon, AstraZeneca, and Merck Serono.
Dr. Adelmann has extensive early and late stage clinical development experience, has led international teams, and was instrumental in various drug submissions. Prior to joining DIA, he served as the Global Head of Merck Serono’s Clinical Pharmacology and Clinical Biomarker operations.
Dr. Adelmann is a member of the American Association of Clinical Pharmacology & Therapeutics, the German Association for Applied Human Pharmacology, a fellow of the Royal Microscopical Society, Oxford, and head lecturer for Clinical Pharmacology at the University of Essen-Duisburg, Germany.